Oncorena AB

📍 Lund, Sweden🗓 Founded 2011👥 7 employees💰 Last funded Jan 2022
Pharmaceutical Manufacturing🌐 oncorena.com
Website LinkedIn
Oncorena is aiming to save human lives by transforming a natural substance into a breakthrough therapy treatment for advanced kidney cancer. We have completed all preclinical studies and are moving into early-stage clinical development. The objective is to confirm the powerful anti-tumor activity of our drug candidate - based on the natural substance orellanine - in advanced kidney cancer patients. Oncorena AB is headquartered in Lund, Sweden.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Oncorena AB?
Oncorena AB has 1 investors on record on gritt.io.
When did Oncorena AB last raise funding?
The most recent investment in Oncorena AB recorded on gritt.io was in January 2022.
When was Oncorena AB founded?
Oncorena AB was founded in 2011.
What industry is Oncorena AB in?
Oncorena AB operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Oncorena AB based?
Oncorena AB is headquartered in Lund, Sweden.